MARKET

HROW

HROW

Harrow Health Inc
NASDAQ
20.51
-0.47
-2.24%
After Hours: 20.51 0 0.00% 16:00 06/08 EDT
OPEN
20.98
PREV CLOSE
20.98
HIGH
21.08
LOW
19.90
VOLUME
396.23K
TURNOVER
0
52 WEEK HIGH
28.25
52 WEEK LOW
6.00
MARKET CAP
617.80M
P/E (TTM)
-31.7296
1D
5D
1M
3M
1Y
5Y
These 14%+ Sucker Yields Could Cut Dividend, But There's A Better Way
Seeking Alpha · 1d ago
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks · 05/30 13:40
Thinking about buying stock in Asure Software, Harrow Health, Sigma Lithium, Delta Air Lines, or Tingo?
PR Newswire · 05/16 15:45
Analysts Initiate Coverage: 5 Stocks for Higher Returns
NASDAQ · 05/15 15:21
Harrow Health falls 23% despite Q1 revenue beat
Seeking Alpha · 05/12 18:12
Why Shares of Harrow Health Are Slumping Friday
Motley Fool · 05/12 17:48
AQST, GSTI and APYX among mid-day movers
Seeking Alpha · 05/12 17:14
Why Heron Therapeutics Shares Are Trading Lower By 34%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Benzinga · 05/12 17:09
More
About HROW
Harrow Health, Inc. is an eyecare pharmaceutical company. The Company is focused on the discovery, development, and commercialization of ophthalmic therapies. The Company serves ophthalmologists and optometrists by providing branded ophthalmic pharmaceuticals and compounded prescription medicines. The Company's specializes in the development, production, sale and distribution of prescription medications that serve unmet needs in the marketplace through its subsidiaries and deconsolidated companies. The Company owns the United States commercial rights to approximately 10 branded ophthalmic pharmaceutical products, including IHEEZO, IOPIDINE (both approved concentrations), MAXITROL eye drops, MOXEZA, ILEVRO, NEVANAC, VIGAMOX, MAXIDEX, and TRIESENCE. The Company owns and operates ImprimisRx, an ophthalmology-focused pharmaceutical-compounding business, and its branded drugs are marketed under its Harrow name.

Webull offers kinds of Harrow Health Inc stock information, including NASDAQ:HROW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HROW stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading HROW stock methods without spending real money on the virtual paper trading platform.